QPS Holdings, LLC

QPS Holdings, LLC is a Contract Research Organization (CRO) focused on clinical research services that encompass preclinical and clinical studies for the pharmaceutical and biotechnology sectors. Founded in 1995 and headquartered in Newark, US, QPS Holdings, LLC specializes in delivering clinical research solutions. The firm operates independently without any known subsidiaries or parent companies. Benjamin Chien, Moshe Geller, Paul Qualls, and Sumika Kawasara are the current CEOs leading the organization.

The company has successfully completed a total of 3 deals, including its acquisition by Argentum, for which financial terms were not disclosed. QPS provides a wide range of clinical research services, including toxicology, drug metabolism and pharmacokinetics (DMPK), bioanalysis, and both early and late-phase clinical trials. The QPS Assay Finder features over 800 validated assays to assist clients in their drug development processes. QPS serves a diverse global client base with significant activities in North America, Europe, and Asia, ensuring efficient project execution tailored to the unique needs of pharmaceutical and biotechnology partners.

The company generates revenue through service contracts with pharmaceutical and biotechnology clients, delivering specialized research and analysis services. These revenue streams include fees for various services such as toxicology studies, DMPK evaluations, and clinical trial support, which are priced based on project scope and complexity. QPS typically engages clients through project-based contracts or long-term partnerships, maintaining a consistent workflow that aligns with research timelines, particularly in oncology, where it has received recent accolades. QPS Holdings, LLC aims to expand its offerings by developing new products and enhancing existing services to better meet client demands.

The company is strategically targeting growth in international markets, specifically in Europe and Asia, by the end of 2024. The recent acquisition by Argentum will support these initiatives, enabling QPS to leverage new resources and capabilities to enhance its global reach and service offerings.